Tower Bridge Advisors’s Pfizer PFE Stock Holding History

Tower Bridge Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.15M	Sell	41,109 -8,991	-18%	-$239K	0.11%	116
2025 Q4	$1.25M	Sell	50,100 -6,000	-11%	-$151K	0.13%	100
2025 Q3	$1.43M	Sell	56,100 -813	-1%	-$20.1K	0.14%	98
2025 Q2	$1.38M	Sell	56,913 -7,075	-11%	-$165K	0.15%	99
2025 Q1	$1.62M	Sell	63,988 -1,009	-2%	-$26.4K	0.18%	94
2024 Q4	$1.72M	Buy	64,997 +1,296	+2%	+$35.2K	0.18%	96
2024 Q3	$1.84M	Sell	63,701 -1,889	-3%	-$55.1K	0.19%	97
2024 Q2	$1.84M	Buy	65,590 +1,563	+2%	+$43K	0.2%	92
2024 Q1	$1.78M	Sell	64,027 -2,400	-4%	-$66.6K	0.18%	102
2023 Q4	$1.91M	Sell	66,427 -2,950	-4%	-$89.2K	0.16%	107
2023 Q3	$2.3M	Buy	69,377 +3,799	+6%	+$134K	0.21%	96
2023 Q2	$2.41M	Sell	65,578 -113,601	-63%	-$4.42M	0.22%	93
2023 Q1	$7.31M	Sell	179,179 -390	-0.2%	-$16.8K	0.6%	57
2022 Q4	$9.2M	Hold	179,569	–	–	0.76%	35
2022 Q3	$7.86M	Sell	179,569 -2,499	-1%	-$121K	0.7%	43
2022 Q2	$9.55M	Sell	182,068 -5,476	-3%	-$279K	0.78%	37
2022 Q1	$9.71M	Sell	187,544 -2,228	-1%	-$116K	0.65%	50
2021 Q4	$11.2M	Sell	189,772 -800	-0.4%	-$39.6K	0.69%	49
2021 Q3	$8.2M	Sell	190,572 -530	-0.3%	-$23.5K	0.55%	57
2021 Q2	$7.48M	Buy	191,102 +5,279	+3%	+$205K	0.5%	62
2021 Q1	$6.73M	Sell	185,823 -10,193	-5%	-$362K	0.51%	62
2020 Q4	$7.22M	Buy	196,016 +18,123	+10%	+$665K	0.59%	53
2020 Q3	$6.19M	Sell	177,893 -1,165	-0.7%	-$40.8K	0.63%	54
2020 Q2	$5.56M	Hold	179,058	–	–	0.62%	52
2020 Q1	$5.55M	Sell	179,058 -1,547	-0.9%	-$52.7K	0.73%	48
2019 Q4	$6.71M	Sell	180,605 -22,658	-11%	-$807K	0.71%	52
2019 Q3	$7.15M	Sell	203,263 -1,502	-0.7%	-$54.6K	0.78%	50
2019 Q2	$8.42M	Buy	204,765 +33	+0%	+$1.31K	0.94%	39
2019 Q1	$8.25M	Buy	204,732 +5,274	+3%	+$211K	0.96%	41
2018 Q4	$8.26M	Sell	199,458 -11,494	-5%	-$477K	1.06%	35
2018 Q3	$8.82M	Sell	210,952 -1,038	-0.5%	-$40K	0.92%	38
2018 Q2	$7.3M	Sell	211,990 -831	-0.4%	-$28.4K	0.81%	44
2018 Q1	$7.17M	Sell	212,821 -6,048	-3%	-$208K	0.79%	46
2017 Q4	$7.52M	Buy	218,869 +141	+0.1%	+$4.81K	0.81%	49
2017 Q3	$7.41M	Sell	218,728 -1,126	-0.5%	-$36.2K	0.84%	48
2017 Q2	$7.01M	Sell	219,854 -10,363	-5%	-$327K	0.8%	51
2017 Q1	$7.47M	Buy	230,217 +116	+0.1%	+$3.66K	0.87%	44
2016 Q4	$7.09M	Sell	230,101 -12,344	-5%	-$377K	0.86%	43
2016 Q3	$7.79M	Sell	242,445 -1,856	-0.8%	-$62.1K	0.95%	39
2016 Q2	$8.16M	Sell	244,301 -498	-0.2%	-$15.9K	1.02%	36
2016 Q1	$6.88M	Sell	244,799 -237	-0.1%	-$6.77K	0.86%	44
2015 Q4	$7.5M	Buy	245,036 +1,855	+0.8%	+$58.4K	0.98%	38
2015 Q3	$7.25M	Buy	243,181 +817	+0.3%	+$26.2K	1%	39
2015 Q2	$7.71M	Buy	242,364 +402	+0.2%	+$13.1K	0.98%	44
2015 Q1	$7.99M	Buy	241,962 +1,863	+0.8%	+$59.2K	1.01%	41
2014 Q4	$7.1M	Buy	240,099 +1,816	+0.8%	+$52.1K	0.87%	48
2014 Q3	$6.69M	Sell	238,283 -1,265	-0.5%	-$35.5K	0.84%	52
2014 Q2	$6.75M	Hold	239,548	–	–	0.83%	53
2014 Q1	$7.3M	Buy	239,548 +766	+0.3%	+$22.8K	0.94%	49
2013 Q4	$6.94M	Buy	238,782 +2,825	+1%	+$82.2K	0.91%	47
2013 Q3	$6.43M	Sell	235,957 -1,350	-0.6%	-$36.7K	0.92%	46
2013 Q2	$6.31M	Buy	+237,307	New	+$6.56M	0.93%	43

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Tower Bridge Advisors's PFE Position: Q1 2026 in Review

Tower Bridge Advisors reduced its Pfizer (PFE) stake by 18% in Q1 2026, selling an estimated $239K and leaving 41,109 shares worth $1.15M. The position accounts for 0.11% of the portfolio, ranked #116.

Tower Bridge Advisors first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.2M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Tower Bridge Advisors held 41,109 shares of Pfizer worth $1.15M as of Q1 2026.
Tower Bridge Advisors sold 8,991 Pfizer shares in Q1 2026, an estimated $239K.
Pfizer made up 0.11% of Tower Bridge Advisors's portfolio in Q1 2026, its #116 holding.
Tower Bridge Advisors first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
Tower Bridge Advisors's Pfizer position peaked at $11.2M in Q4 2021.
2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Tower Bridge Advisors's 13F filing for Q1 2026, filed 12 May 2026.